Cresset Asset Management, LLC
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1761013
Chicago, IL
Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,130,919
+$171,083 QoQ
Shares Held
86,063
+2.5% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 91.05887547494278.ToString("F0")%
Shared 0.ToString("F0")%
None 8.941124525057226.ToString("F0")%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cresset Asset Management, LLC holds $84,055,568 across 41 Biotechnology names. CPRX ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
739,191 | $38,630,121 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
259,397 | $16,764,828 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,860 | $3,509,804 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
13,633 | $2,577,318 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
86,063 | $2,130,919 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
72,435 | $2,028,904 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,537 | $1,960,187 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
11,860 | $1,478,349 |
All Filings in CPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,130,919 | 86,063 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,959,836 | 83,969 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,650,978 | 83,806 | Shares | Sole | 2026-01-22 | |
| 2025-06-30 | $1,724,216 | 79,457 | Shares | Sole | 2026-01-22 | |
| 2025-03-31 | $308,096 | 12,705 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||